QVT Financial LP - Q1 2018 holdings

$953 Million is the total value of QVT Financial LP's 53 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 36.1% .

 Value Shares↓ Weighting
XBI BuySPDR SERIES TRUSTput$174,065,000
+37.2%
1,984,100
+32.7%
18.26%
+155.0%
 MICRON TECHNOLOGY INCnote 2.125% 2/1$145,828,000
+26.5%
30,604,0000.0%15.29%
+135.1%
 VERISIGN INCsdcv 3.250% 8/1$91,967,000
+2.8%
26,624,0000.0%9.64%
+91.1%
XBI BuySPDR SERIES TRUSTs&p biotech$66,417,000
+131.8%
757,067
+124.3%
6.97%
+330.8%
 MICROCHIP TECHNOLOGY INCnote 1.625% 2/1$47,099,000
+3.7%
26,541,0000.0%4.94%
+92.8%
BuyINTEL CORPsdcv 3.250% 8/0$43,354,000
+570.0%
17,190,000
+493.8%
4.55%
+1145.8%
MMYT SellMAKEMYTRIP LIMITED MAURITIUS$39,806,000
-2.8%
1,200,001
-15.3%
4.18%
+80.7%
 ADVANCED MICRO DEVICES INCnote 2.125% 9/0$29,370,000
-2.8%
20,000,0000.0%3.08%
+80.8%
 HERBALIFE LTDnote 2.000% 8/1$24,929,000
+20.1%
20,510,0000.0%2.62%
+123.3%
KANG BuyIKANG HEALTHCARE GROUP INCsponsored adr$22,972,000
+52.8%
1,151,464
+21.0%
2.41%
+184.1%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$22,534,000
+161.6%
1,411,695
+25.6%
2.36%
+386.2%
GNRT BuyGENER8 MARITIME INC$19,559,000
+347.1%
3,637,189
+450.3%
2.05%
+730.4%
GDS NewGDS HLDGS LTDsponsored adr$14,924,000573,736
+100.0%
1.56%
FTSI NewFTS INTERNATIONAL INC$14,793,000804,386
+100.0%
1.55%
XLRN  ACCELERON PHARMA INC$14,093,000
-11.1%
373,4810.0%1.48%
+65.1%
AGEN SellAGENUS INC$13,174,000
+34.5%
2,995,830
-6.4%
1.38%
+149.9%
ATEX SellPDVWIRELESS INC$11,930,000
-14.9%
514,396
-0.4%
1.25%
+58.2%
NYT SellNEW YORK TIMES COcl a$11,252,000
-20.7%
466,889
-39.1%
1.18%
+47.3%
NRE  NORTHSTAR REALTY EUROPE CORP$11,171,000
-6.6%
891,0000.0%1.17%
+73.6%
HD  HOME DEPOT INC$10,223,000
-6.0%
57,3570.0%1.07%
+74.9%
FB NewFACEBOOK INCcl a$9,763,00061,100
+100.0%
1.02%
HUNTF  HUNTER MARITIME ACQUISITIONcl a$9,752,000
+0.9%
1,000,0000.0%1.02%
+87.7%
TRCO BuyTRIBUNE MEDIA COcl a$9,544,000
+197.5%
235,600
+211.9%
1.00%
+453.0%
KMX  CARMAX INC$9,369,000
-3.4%
151,2530.0%0.98%
+79.7%
JPM  JPMORGAN CHASE & CO$8,341,000
+2.8%
75,8490.0%0.88%
+91.0%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$7,835,000
+43.1%
731,510
-14.3%
0.82%
+166.0%
ARGX SellARGENX SEsponsored adr$7,302,000
-35.6%
93,034
-48.2%
0.77%
+19.7%
FRAC BuyKEANE GROUP INC$7,085,000
+9.6%
478,695
+40.8%
0.74%
+103.6%
AVXS  AVEXIS INC$6,157,000
+11.7%
49,8230.0%0.65%
+107.7%
PTEN BuyPATTERSON UTI ENERGY INC$5,269,000
-21.3%
300,933
+3.4%
0.55%
+46.3%
WFC  WELLS FARGO CO NEW$5,152,000
-13.6%
98,3000.0%0.54%
+60.2%
SBGI SellSINCLAIR BROADCAST GROUP INCcl a$4,761,000
-54.3%
152,123
-44.7%
0.50%
-15.1%
CALM  CAL MAINE FOODS INC$4,497,000
-1.7%
102,8960.0%0.47%
+82.9%
TTWO NewTAKE-TWO INTERACTIVE SOFTWAR$4,140,00042,344
+100.0%
0.43%
LBRT NewLIBERTY OILFIELD SVCS INC$4,065,000240,700
+100.0%
0.43%
NXST SellNEXSTAR MEDIA GROUP INCcl a$3,642,000
-36.2%
54,767
-25.0%
0.38%
+18.6%
EQT  EQT CORP$3,246,000
-16.5%
68,3230.0%0.34%
+55.3%
EURN SellEURONAV NV ANTWERPEN$2,968,000
-65.9%
361,948
-61.6%
0.31%
-36.8%
GNK NewGENCO SHIPPING & TRADING LTD$1,919,000134,935
+100.0%
0.20%
NAT SellNORDIC AMERICAN TANKERS LIMIput$1,564,000
-37.6%
806,200
-25.8%
0.16%
+16.3%
BMRN SellBIOMARIN PHARMACEUTICAL INC$1,153,000
-18.8%
14,223
-10.7%
0.12%
+51.2%
EGLE NewEAGLE BULK SHIPPING INC$1,127,000227,746
+100.0%
0.12%
BLUE SellBLUEBIRD BIO INC$858,000
-30.6%
5,027
-27.5%
0.09%
+28.6%
GLF  GULFMARK OFFSHORE INC$706,000
+14.8%
26,9800.0%0.07%
+111.4%
ICPT SellINTERCEPT PHARMACEUTICALS IN$692,000
-14.5%
11,254
-18.8%
0.07%
+58.7%
 VECTOR GROUP LTDfrnt 1/1$672,000
-9.4%
467,0000.0%0.07%
+66.7%
ACAD SellACADIA PHARMACEUTICALS INC$646,000
-30.9%
28,736
-7.4%
0.07%
+28.3%
HYG  ISHARES TRiboxx hi yd etf$588,000
-1.8%
6,8700.0%0.06%
+82.4%
SRPT SellSAREPTA THERAPEUTICS INC$499,000
-48.0%
6,731
-60.9%
0.05%
-3.7%
TSRO SellTESARO INC$343,000
-64.3%
6,005
-48.3%
0.04%
-33.3%
VGR  VECTOR GROUP LTD$233,000
-9.0%
11,4280.0%0.02%
+71.4%
TCON SellTRACON PHARMACEUTICALS INC$102,000
-74.3%
45,869
-63.3%
0.01%
-50.0%
HNTWF  HUNTER MARITIME ACQUISITION*w exp 99/99/999$30,000
+100.0%
500,0000.0%0.00%
+200.0%
RDFN ExitREDFIN CORP$0-7,970
-100.0%
-0.01%
IIVI ExitII VI INC$0-84,509
-100.0%
-0.22%
CTRP ExitCTRIP COM INTL LTD$0-113,300
-100.0%
-0.28%
HIMX ExitHIMAX TECHNOLOGIES INCsponsored adr$0-483,500
-100.0%
-0.28%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-29,500
-100.0%
-0.29%
ExitJEFFERIES GROUP INC NEWdbcv 3.875%11/0$0-6,500,000
-100.0%
-0.37%
QRVO ExitQORVO INC$0-105,000
-100.0%
-0.40%
NAT ExitNORDIC AMERICAN TANKERS LIMI$0-3,703,929
-100.0%
-0.48%
ADS ExitALLIANCE DATA SYSTEMS CORP$0-41,151
-100.0%
-0.59%
IBKR ExitINTERACTIVE BROKERS GROUP IN$0-211,274
-100.0%
-0.71%
GS ExitGOLDMAN SACHS GROUP INC$0-56,832
-100.0%
-0.82%
TWX ExitTIME WARNER INC$0-228,244
-100.0%
-1.18%
ABUS ExitARBUTUS BIOPHARMA CORP$0-16,013,540
-100.0%
-4.56%
AXGT ExitAXOVANT SCIENCES LTD$0-75,000,000
-100.0%
-22.30%
MYOV ExitMYOVANT SCIENCES LTD$0-37,231,342
-100.0%
-26.56%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings